Can Too is a community of passionate and inspired people fighting cancer through fitness and investment in Australian research. Our partners are vital members of this community and we have specially designed partnership offerings to recognise and value the investment.
Our partnerships are collaborative and are created to engage your employees, maximise your brand exposure, build social equity and fulfil Corporate Social Responsibility objectives.
A pro-bono social impact study carried out by independent consultants has shown that every $1 invested in Can Too delivers a ~$3.58 Social Return on Investment (SROI).
Partnering with the Can Too Foundation is investing in impact
Reducing risk of cancer through transforming exercise and lifestyle habits of participants
Improving mental health and quality of life for participants through both exercise and the connections the Can Too community provides
Changing the future of cancer - as part of the unique Can Too Foundation model, program participants raised $1.83 million in 2017 for . This funding has supported 14 cancer research projects in NSW, WA, Vic, SA and Qld.
The Can Too Foundation invests in the most promising in Australia through Cure Cancer Australia, Cancer Council NSW, Children's Cancer Institute, Garvan Institute and Kolling Institute. Past research grant recipients have made breakthroughs in their research and our funding ensures these discoveries continue.
Join Us to Fight Cancer
If you’re passionate about fighting cancer, health and wellbeing, inspiring communities and transforming the lives of future generations, we’d love to partner with you! We have Major Partner and Program Partner opportunities, as well as the option to .
Get in touch to discuss how we can
Hero status in a highly engaged community that values an active lifestyle, wellbeing, connection and altruism.
Lasting social capital through alignment with Can Too’s positive, widely-recognised brand in the health and wellbeing sector.
Real outcomes in the community through health promotion and cancer research.
“Since 2005, we have seen Can Too very successfully leverage Macquarie’s seed funding and then ongoing core funding support for its program costs. The close to $3 million our Foundation has invested in Can Too over that time has greatly amplified the dollars committed to cancer research, specifically those projects deemed most promising in their potential to find a cure. Together we have enjoyed a solid partnership, providing a range of non-grant related support as well - such as CEO mentoring, board membership and database investment - in our wish to see the organisation succeed. This has continued through Can Too’s transition into an independent foundation in October 2014 and to the present day.”
— Lisa George, Head of Macquarie Group Foundation